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Heterochromatin is a minimally transcribed, densely bundled complex of DNA 
and associated factors comprising large regions of the eukaryotic genome. It is essential 
for chromosome stability, genome integrity, gene regulation, and the silencing of 
transposons. The filamentous fungus Neurospora crassa is often employed as a model 
organism to study the epigenetic regulation ofheterochromatin. In Neurospora, the 
conserved scaffolding protein heterochromatin protein 1 (HP 1) binds H3 histones 
marked by lysine nine trimethylation (H3K9me3) and recruits other proteins to form at 
least four distinct complexes. HPl recruits the DIM-2 DNA methyltransferase, which 
catalyzes DNA methylation, and the Mi-2 chromatin remodeler, which promotes 
centromeric silencing. HPI is also an essential component of the HCHC complex, 
which facilitates histone deacetylation, and the DMM complex, which limits aberrant 
heterochromatin spreading. However, it is unclear how these disparate functions are 
coordinated. We hypothesized that they are modulated by post-translational 
modifications (PTMs) of HPI. Previously, we used mass spectrometry to identify HPl 
sites harboring methylation, acetylation, formylation, and phosphorylation. I used 
amino acid substitutions at a subset of these sites to prevent individual PTMs in vivo. 
Substitutions at multiple sites were found to cause a substantial decrease in centromeric 
silencing independent of DNA methylation. These results suggest that the recruitment 
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Epigenetics: The Language of Life 
DNA is commonly referred to as the blueprint of life, but discoveries in the past 
few decades have challenged this notion. At the completion of the human genome 
project, many researchers were shocked to discover that the entire human genome 
contains only 3.2 billion base pairs, or about 770 megabytes of information1–3. That 
means a DVD has more than six times the storage capacity of your genome. 
Furthermore, this sequence contains only 20,000-25,000 genes. In light of this, it 
became clear that the information contained in the DNA sequence is only part of the 
picture. 
We now understand that the genome functions more like a dictionary than a 
complete set of instructions. The dictionary is a complete catalogue of the words we use 
to convey ideas, but the true complexity and versatility of language is derived from our 
ability to choose the words we need and to connect them in a meaningful way. In an 
analogous manner, every cell in the body has the same DNA sequence, but they all read 
different parts of it. Rather than blindly following instructions in the genome, each cell 
precisely expresses combinations of genes that function together within the context of 
its environment. Much of the variation between cells in an organism and between 
organisms in a population is caused not by differences in DNA sequence, but by 
differing patterns of gene expression. However, we are just beginning to understand 




Epigenetics and Chromatin Structure 
Epigenetics is the study of semi-heritable changes in gene expression or 
phenotype not directly caused by the DNA sequence. Rather, epigenetic traits are 
usually mediated by factors affecting the physical organization of DNA within a cell. In 
the nucleus of eukaryotes, DNA is stored in a complex with proteins and RNA. This 
complex is known as chromatin. If chromatin were unraveled, it would reveal sections 
of free DNA suspended between periodically spaced bundles known as nucleosomes, 
which are the basic unit of chromatin (Fig. 1A). At each nucleosome, the DNA strand is 
wound around a core of eight histones proteins, of which there are four types with two 
copies each: H2A, H2B, H3, and H4 (Fig. 1B). Each histone has a flexible chain of 
amino acids that protrudes from a more compactly folded globular core. These 
protrusions are known as histone tails, and they play an important role in determining 
chromatin structure and gene expression. 
Chromatin can occur in two major conformations. Transcriptionally active genes 
are found in euchromatin, where the nucleosomes are loosely organized in such a way 
that DNA is accessible to the proteins involved in gene expression. In contrast, the 
nucleosomes of heterochromatin are packed together more tightly, causing nearby genes 
to have minimal transcription. Heterochromatin stabilizes chromosomes by forming 
large organizational structures including centromeres and telomeres4,5. In addition, the 
proper formation and maintenance of heterochromatin is critical to a wide variety of 
functions, including cellular differentiation, the regulation of gene expression, and the 





Figure 1: Chromatin Composition and Conformation 
A) Chromatin is an efficient and well-organized system for storing DNA and regulating 
its accessibility. B) The two distinct states of chromatin conformation are distinguished 
by the spacing of nucleosomes. Figures were adopted from A) Iyer et al. 20119 and 
B) Russ et al. 201210.  
Abnormalities affecting chromatin structure have been implicated in tumor 
development, autism, cardiovascular disease, and a number of other human health 
problems11–13. Despite the fundamental importance of heterochromatin for a wide 
variety of essential biological functions, many of the details surrounding 
heterochromatin formation and maintenance are poorly understood. A better 
understanding of the regulation of heterochromatin could provide targets for new drugs 
and therapeutic strategies to treat the underlying epigenetic causes of some human 
health problems14. 
Heterochromatin Establishment in Neurospora 
The filamentous fungus Neurospora crassa is an ideal model organism for 




characteristics of heterochromatin with more complex eukaryotes, including humans. In 
Neurospora and in higher eukaryotes, cytosine methylation in DNA (5-methylcytosine, 
or 5mC) is one of the primary signals associated with heterochromatin15. Although 
DNA methylation is found in Neurospora, it is not required for the organism's survival. 
This feature allows the study of Neurospora mutants that are defective in methylation 
(DIM). Studies of these mutants have successfully identified a number of genes 
required for DNA methylation and the subsequent establishment of heterochromatin in 
Neurospora. 
In addition to DNA methylation, several post-translational modifications 
(PTMs) of histone proteins are involved in the control of chromatin structure and gene 
expression16. Two of the most prominent epigenetic marks are found on lysine nine in 
the tail of histone H3 (H3K9). H3K9 acetylation (H3K9ac), or the addition of an acetyl 
group to H3K9, is associated with euchromatin and active genes7. This site can also be 
modified by the addition of a methyl group through a process fittingly known as 
methylation. Trimethylated H3K9 (H3K9me3), which carries three methyl groups, is a 
hallmark of heterochromatin and gene inactivation17. 
Almost all DNA methylation in Neurospora is found at relics of transposons that 
have been modified by repeat-induced point mutation (RIP). Transposons are segments 
of DNA that use the cell's machinery to move around the genome, sometimes creating 
many copies of themselves that are inserted at multiple sites. To prevent transposons 
from interrupting important genes, it is necessary to silence them before they have a 
chance to spread. For this purpose, Neurospora uses RIP, which mutates the duplicate 




result18. These A:T-rich regions serve as targets for the DIM-7 protein, which is 
required for localization of the DIM-5 histone H3K9 methyltransferase and three other 
associated proteins that are collectively known as DCDC (the DIM-5/-7/-9, 
CUL4/DDB1 complex, Fig. 2A). DCDC mediates the DIM-5-catalyzed trimethylation 
of H3K919,20. 
 
Figure 2: Heterochromatin Establishment in Neurospora 
A) A:T-rich DNA is targeted by the DCDC complex, which methylates H3K9. HP1 
binds H3K9me3 and recruits the following: B) DIM-2, a DNA methyltransferase 
responsible for all DNA methylation in Neurospora, C) the HCHC centromeric 
silencing complex involved in histone deacetylation, or D) the DMM complex, which 
prevents excessive heterochromatin spreading. The HP1-Mi-2 complex is not shown. 
H3K9me3 is targeted by heterochromatin protein one (HP1), which is an evolutionarily 
conserved scaffolding protein involved in at least three distinct complexes affecting 
chromatin structure21. HP1 interacts with the DIM-2 DNA methyltransferase to mediate 




proteins CDP-2, HDA-1, and CHAP to form the HCHC complex, which facilitates 
heterochromatin establishment at centromeres and transposon relics through the 
deacetylation of histones at H3K9 and other sites (Fig. 2C)21. These functions work 
together to establish heterochromatin formation. 
Alternatively, HP1 can form the DNA methylation modulator complex (DMM 
complex) by recruiting the proteins DMM-1 and DMM-2 (Fig. 2D). The DMM 
complex prevents H3K9me3 and DNA methylation from spreading beyond the 
boundaries of methylated regions and silencing neighboring genes23, which can be 
required for important functions. Because it has close sequence similarity (homology) to 
proteins that remove methylation (demethylase proteins), it has been suggested that the 
DMM-1 protein may act as a histone demethylase that targets H3K9me3 at the borders 
of heterochromatin domains. However, in vitro experiments have cast doubt on this 
hypothesis. Regardless of the exact mechanism, the HCHC complex and DIM-2 work in 
parallel to promote heterochromatin formation, while the DMM complex antagonizes 
these functions to protect heterochromatin boundaries. More recently, the Neurospora 
homologue of the Mi-2 chromatin remodeler has been identified as a fourth interacting 
partner of HP1 (Honda et al, manuscript in preparation). In Neurospora and in humans, 
Mi-2 plays a major role in the establishment and maintenance of pericentric 
heterochromatin, suggesting a significant degree of functional conservation24. 
Thus, HP1 can facilitate at least four distinct functions that are essential to 
heterochromatin establishment and maintenance. However, the regulation of these 
activities is poorly understood. How does an HP1 protein recruit the correct groups to 




proteins could be the key to understanding how the activities of its associated 
complexes are coordinated. Ultimately, this understanding could connect the known 
heterochromatin complexes within a larger regulatory network that is responsive to 
environmental signals. 
Background Work and Hypothesis 
Studies in mammals, fission yeast, and Drosophila have revealed extensive 
modification of the HP1 protein itself, similar to that seen in histones25,26. Using a 
technique known as mass spectrometry to identify PTMs of Neurospora HP1, my 
mentor, Tereza Ormsby, detected widespread phosphorylation, acetylation, methylation, 
and formylation (Fig. 3). PTMs were detected in every functional region of the protein, 
but not with equal distribution. Serine phosphorylation was detected in a small cluster 
of two to four sites in close proximity to the terminus in both the N and C terminal 
domains, neither of which was detected to have any other PTM. The highest occurrence 
of PTMs was found in the protein's hinge region, which is a poorly conserved linker 
domain involved in localization to chromatin27,28. A number of modifications were also 
detected in the chromodomain (CD), which is partially responsible for binding 
H3K9me327,29, and the chromoshadow domain (CSD), which facilitates 




Figure 3: HP1 PTMs Detected by Mass Spectrometry 
The horizontal bar represents the amino acid sequence of the HP1 protein from the N 
terminus on the left to the C terminus on the right. PTMs marked by a red asterisk were 
detected in two different facilities at which testing was performed. CD refers to the 
chromodomain and CSD designates the chromoshadow domain. The blue arrows 
indicate the subset of sites that I analyzed. 
 
PTMs are often used to regulate protein function, and HP1 is heavily modified31. 
Furthermore, HP1's centrality in the constitutive heterochromatin pathway could allow 
it to behave as a fulcrum for the regulation of chromatin state; it is uniquely situated to 
control activity in the four downstream complexes it interacts with. This led us to 
hypothesize that HP1's interactions with DIM-2, the HCHC complex, the DMM 
complex, and Mi-2 are regulated by its PTMs. It was further hypothesized that there are 
multiple pools of HP1 with unique PTMs and distinct functions.  
Objectives and Experimental Strategy 
In this study, we aimed to determine whether PTMs are required for normal HP1 
function and proper regulation of heterochromatin. Furthermore, we examined whether 




manner, as opposed to having a more general role in HP1 function. Many proteins 
undergo modification, but not all are regulated by it. Some proteins undergo extensive 
processing before reaching their mature, functional form32. Are the HP1 PTMs innate to 
the mature HP1 protein and required for its function and stability, or do they act as a set 
of inducible switches that could allow HP1 to dynamically adjust its activity to local 
conditions or signals from a greater regulatory network? Our study design enabled us to 
differentiate between these two distinct schemes. To this end, our general aim was 
subdivided into four primary research objectives. 
Objective 1: Substitute PTM Sites 
To determine each PTM's role in HP1 function, it would be necessary to 
eliminate them individually and measure any resulting changes. However, there is no 
known method that can eliminate modification at a specific site in vivo. To work around 
this problem, I replaced sites suspected to harbor PTMs with other amino acids that 
were biochemically similar, but not subject to modification. This strategy has been 
successfully employed in a number of previous studies elucidating the significance of 
PTMs in other proteins, including in histones33–36. I used this strategy to prevent 
phosphorylation, methylation, acetylation, and formylation of a number of amino acids, 
and also to mimic the hyperacetylation of lysine. 
Lysine is positively charged, but acetylation makes the site effectively neutral 
under biological conditions. Arginine is positively charged and has a very similar 
structure to lysine, but it cannot be acetylated (Fig. 4A). Arginine substitution was used 
to prevent acetylation at sites where lysine acetylation was detected. In contrast, 




Glutamine has similar properties to acetyl-lysine, but it can't be de-acetylated because it 
doesn't actually have an acetyl group (Fig. 4B). For this reason, glutamine substitution 
was chosen to mimic the constitutive acetylation of lysine. 
 
Figure 4: Substitution of Lysine to Prevent or Mimic Acetylation 
A) Lysine's positive charge is reduced by acetylation. Arginine prevents acetylation and 
mimics lysine in its positively charged, unmodified state. B) Glutamine mimics the 
charge and structure of acetyl lysine, but it cannot be deacetylated. Glutamine 
substitution therefore mimics the constitutive acetylation of lysine. 
Although arginine is a good mimic of unmodified lysine, it cannot be used to prevent 
methylation or formylation. Instead, leucine substitution was used to prevent lysine 
methylation and formylation at suspected PTM sites. While leucine is less 
biochemically similar to lysine than arginine is, it will still disrupt any interactions that 
depend on methylation or formylation, and based on past studies, it is unlikely to cause 
protein misfolding with a single substitution33. A similar strategy was employed to 
prevent phosphorylation. Phenylalanine was used to prevent the phosphorylation of 
tyrosine, and alanine was used to prevent phosphorylation of serine and threonine. Due 
to the immense scale of the project and the considerable amount of labor required for 
each mutant, my research focused on a subset of the PTM sites, while my mentor dealt 




Objective 2: Test the Role of HP1 PTMs in Facilitating DNA Methylation 
Testing our research hypothesis required an evaluation of function for each of 
the four complexes normally containing HP1. For each mutant generated by the first 
objective, I assessed DNA methylation at multiple heterochromatin domains and 
compared it to wild-type (WT) levels. DNA methylation in heterochromatin domains 
was used as an indicator of DIM-2 activity. DNA methylation is lost across the genome 
in the absence of functional DIM-2 or HP1, while partial defects in DIM-2 activity 
confer a reduction in DNA methylation. Detection of normal DNA methylation can 
serve as decisive evidence that a missing PTM is not required for DIM-2 function. 
Defects in the other HP1 partners are accompanied by characteristic changes in the 
pattern of DNA methylation that can be used as an indicator of their activity. 
Objective 3: Assess Heterochromatin Spreading in Mutants 
DNA methylation was also assessed at regions that are normally euchromatic, 
but lie just outside of a heterochromatin domain. The DMM complex is required to limit 
heterochromatin spreading, so increased methylation in these border regions is 
indicative of DMM defects. Loss of Mi-2 causes 5mC-spreading at some regions of the 
genome, but it leaves the 8:G3 flanks unaffected. 
Objective 4: Test Centromeric Silencing 
HCHC and Mi-2 are required for normal heterochromatin formation at the 
centromeres. While genes are not naturally located in the pericentric heterochromatin, 
the state of chromatin in the centromere can be assessed by inserting a gene into the 




gene (bar) into the pericentric heterochromatin enables centromeric gene expression to 
be ascertained by measuring resistance to the corresponding drug (Basta). While strains 
with WT HP1 are unable to grow on Basta due to silencing of the centromeric bar gene, 
strains with defects in the activity of HCHC or Mi-2 exhibit decreased centromeric 
silencing and increased growth in the presence of Basta. 
A second test was used to differentiate between these two potential causes of 
decreased silencing in the centromere. Discrimination between the two pathways was 
achieved by measuring DNA methylation at the centromere. In strains with defective 
recruitment of the HCHC complex, the loss of centromeric silencing is accompanied by 
a paradoxical increase in centromeric DNA methylation21. This effect is not observed in 
Mi-2-deficient strains, so it is a useful indicator of HCHC defects (Honda et al, 
manuscript in preparation). Together, these research objectives make it possible to 
eliminate individual PTMs from HP1 and detect resulting changes in the activity of 
each of its four associated complexes: DIM-2, the HCHC complex, the DMM complex, 
and Mi-2. 
Introduction to Research Techniques 
To facilitate reading by an interdisciplinary audience, I have included this 
section explaining the principles of the major techniques employed in this study. 
Site-Directed Mutagenesis 
Site-directed mutagenesis is used to generate desired mutations at specific sites 
in a DNA sequence. The basis of this technique is the polymerase chain reaction (PCR), 




sequence. DNA polymerase cannot initiate replication without primers. A primer is a 
short piece of DNA that binds to a matching complementary sequence in the DNA 
template and serves as the beginning of a new replicate strand, which is extended by 
DNA polymerase. Site-directed mutagenesis uses PCR primers that don't perfectly 
match the complementary template sequence, but still initiate replication. The errors in 
the primers are incorporated into the new copies of DNA. In this way, primer sequences 
can be designed to introduce specific mutations at predetermined sites during PCR site-
directed mutagenesis. 
Molecular Cloning and Recloning 
Molecular cloning is a set of techniques that enables researchers to manipulate 
and modify DNA sequences in vitro. It also allows them to efficiently prepare large 
quantities of genetic material for experimentation. Molecular cloning takes advantage of 
various genetic tools, such as plasmids and specific enzymes that are used naturally by 
bacterial cells. Plasmids are relatively small rings of DNA that can be copied 
prolifically and shared between bacterial cells. This allows bacteria to exchange useful 
genes, like those involved in antibiotic resistance. Researchers use plasmids as a 
convenient vehicle to carry engineered DNA sequences (vectors) into a host organism.  
While the process is highly amenable to adaptation for a wide variety of 
purposes, a basic cloning procedure might be performed as follows: First, plasmids are 
isolated from a bacterial culture. Then, the gene or sequence of interest (the insert) is 
incorporated into the plasmid vector. This is accomplished with restriction enzymes 
(endonucleases), which cleave DNA at specific target sequences called restriction sites. 




the gene of interest, liberating it from the extraneous surrounding DNA. The same 
restriction enzyme is also used to cleave the plasmid at a desired location in its DNA 
sequence (a locus), leaving it free to accept the gene. An enzyme-mediated reaction 
known as ligation joins the free ends of the gene segment with the free ends of the 
plasmid, effectively integrating the gene into the recircularized plasmid.  
The recombinant plasmid can then be transferred back into a bacterial host 
through a process known as transformation. Transformation uses heat or electric shock 
to make the bacterial cell membrane more permeable, which causes some fraction of 
cells to accept foreign genetic material. Plasmid vectors are designed to include 
antibiotic resistance genes so that growth on antibiotic-containing media will select for 
cells that accepted the plasmid. The transformed bacteria will rapidly replicate the 
plasmid during exponential growth, allowing large quantities of it to be easily isolated. 
The recombinant gene sequence can further be excised and recloned into other vectors 
if desired. 
His-3-Targeting Transformation by Electroporation 
While genes can be easily transformed into bacteria as plasmids, many 
eukaryotes do not use plasmids, and they are not imported into the nucleus of 
Neurospora37. Foreign DNA must be integrated into the nuclear genome if it is to 
become a stable part of the genotype of Neurospora. His-3-targeting transformation is a 
technique that allows genes to be inserted into the Neurospora genome just downstream 
of the his-3 gene, which encodes an enzyme required for the biosynthesis of the amino 
acid histidine. This technique takes advantage of genetic recombination. Recombination 




can also facilitate crossover between any two DNA strands with close sequence 
similarity (homology). 
To promote recombination into the his-3 locus, a gene of interest is first 
recloned into the his-3-targeting plasmid pBM61. Plasmid pBM61 contains a truncated 
copy of the his-3 gene and a multiple cloning site with restriction sites for insertion of 
the desired gene followed by a segment of 3' flanking, non-coding sequence from 
linkage group I (LGI), which is just downstream of the his-3 gene.  
To force Neurospora to accept recombinant sequence, we use a process known 
as electroporation, during which a small electrical current is applied to permeabilize 
asexual Neurospora spores (conidia)38. The recipient conidia are engineered to have a 
defective copy of his-3 with a loss-of-function mutation near the 3' end of the gene. 
Consequently, they require histidine supplementation for growth. In a small fraction of 
the electroporated cells, recombination of the defective, endogenous his-3 gene with the 
his-3-targeting DNA will generate a functional version of the his-3 gene (Fig. 5A). A 
second crossover completes the insertion by linking the 3' flanking sequence of his-3 
with the rest of linkage group I (Fig. 5B). The transformed cells are grown on agar 
plates in the absence of histidine to select for cells in which the function of his-3 was 






Figure 5: His-3-Targeting Transformation by Electroporation 
A) 5'Δhis-3 designates a truncation at the 5' end of a his-3 gene that is otherwise 
functional. The red stripe in the lower his-3 indicates a loss of function mutation. 
Recombination between the two restores the function of his-3. B) Sitting downstream 
of the desired gene, a duplicate segment of the his-3 3' flank recombines back into its 
endogenous locus, carrying the gene with it. The reciprocal recombination product is 
not depicted in this illustration, because it is not integrated into the Neurospora genome. 
Gel Electrophoresis and Purification 
Gel electrophoresis is a technique used to separate biological macromolecules 
based on their size and charge. The technique can be used to analyze samples 
containing a mixture of proteins or distinct fragments of DNA or RNA. During 
electrophoresis, a rectangular gel slab composed of agarose or polyacrylamide is 
commonly submerged beneath a buffer solution, although other setups with gel columns 
or capillary tubes can also be used. Liquid samples are loaded into small "wells," or 
gaps in the gel, and an electric current is run across it horizontally. Under the conditions 
most commonly used for electrophoresis, the biological macromolecules are negatively 
charged, and will migrate towards the positive electrode (cathode). To move towards 
the cathode, macromolecules must squeeze through microscopic pores in the gel. 




resistance than large molecules. Through this process, dissimilar fragments in a sample 
will separate into distinct bands based on their size and charge, with each band 
containing many copies of a single fragment or multiple fragments with similar size and 
charge. While DNA is typically electrophoresed in agarose gels, proteins are most 
commonly separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE). 
The banding pattern of DNA or protein fragments can be visualized with a 
variety of stains. The distance a molecule travels through the gel is inversely related to 
its size, and the number of bands in the gel is equal to the number of fragments with 
unique size, although this is not always discernable. In addition, highly concentrated 
fragments will produce thick bands that stain heavily when compared to fragments 
occurring in smaller amounts. In this way, gel electrophoresis can often be used to count 
the different fragments in a sample, determine their approximate sizes, and estimate 
their relative concentrations. Electrophoresis is also useful for purification. After the 
molecules in a sample separate by size, fragments of the desired size can be excised 
from the gel, and the DNA or protein can be purified from them. 
Blot Analysis 
Although the fragments in a gel can be visualized by staining after 
electrophoresis, the available stains cannot selectively bind to a single desired 
macromolecule. In some situations, like the electrophoretic analysis of a lysate with 
hundreds of different proteins, or of genomic DNA digested by a restriction enzyme to 
give thousands of DNA fragments, all of the bands will blur together to produce a 




be used to visualize only the fragment of interest. I used two different types of blots 
during the course of this study, which are distinguished by the class of macromolecule 
they analyze. "Southern blots" are used for DNA samples, while "western blots" are 
used for proteins39–41. 
Despite some procedural differences, these blots all use the same basic principle. 
After segregation during electrophoresis, macromolecules are drawn out of the gel by 
capillary force or electric current. The fragments are deposited on a high-affinity 
binding membrane resting on the gel. The blotting membrane retains the same banding 
pattern as the electrophoresed gel. However, the membrane leaves these 
macromolecules accessible to direct interaction with reagents that can visualize them in 
a much more selective manner. 
Proteins on a western blot are selectively visualized with specialized antibodies 
that recognize and bind to a specific protein sequence, known as an epitope40,41. Genetic 
engineering can be used to physically link proteins of interest with distinctive epitopes, 
which are referred to as affinity tags (e.g. FLAG tag)42. To facilitate detection of tagged 
proteins, antibodies are commonly linked to the horseradish peroxidase (HRP) enzyme. 
HRP catalyzes the chemiluminescence reaction between luminol and hydrogen 
peroxide, producing a detectable light signal wherever the antibody binds its target 
protein. I used western blot analysis to verify expression of the FLAG-tagged HP1 
protein in engineered Neurospora strains. 
Hybridization probes, which contain complementary sequence to a desired 
fragment of DNA, are used to visualize specific nucleotide sequences in Southern blots. 




phosphorus-32 isotope (32P) into the reaction product. The resulting probe will 
selectively bind to the target sequence and impart radioactivity to the corresponding 
bands on the membrane. Exposure of a photosensitive film or phosphor screen allows 
these specific bands to be visualized. 
In conjunction with a restriction digest, this technique has a number of practical 
applications. Southern analysis can be used to determine whether an insert has been 
integrated between known restriction sites at a desired locus (such as his-3). Such an 
insertion will cause a predictable increase in the length and molecular of mass of the 
segment between the two sites, which is excised during the appropriate restriction 
digest. Probing a Southern blot for the planned insertion site and evaluating the band 
migration distance can detect this increase. 
A variant of this strategy uses Southern analysis to assess DNA methylation. In 
this method, a DNA sample is digested separately with two different restrictions 
enzymes that target the same sequence (isoschizomers). One of the enzymes cleaves its 
target regardless of cytosine DNA methylation, but the other can only cut unmethylated 
restriction sites, and is said to be 5mC-sensitive. The isoschizomers DpnII (cytosine 
methylation-insensitive) and BfuCI (cytosine methylation-sensitive) are commonly used 
for this purpose. If a locus is methylated, Southern analysis will reveal larger fragments 
in the BfuCI digest that are not present in the DpnII digest, along with a corresponding 
decrease of smaller fragments in the BfuCI digest. The level of DNA methylation at a 
site is deduced from the ratio of large (methylated) and small (unmethylated) fragments 
in the BfuCI digest. By probing for a variety of regions across the genome, patterns of 





Site-Directed Mutagenesis  
For site-directed mutagenesis, my mentor prepared a construct of hpo in the 
pBluescript KS+ vector (pBSK from Stratagene), which is smaller and more conducive 
to PCR mutagenesis than other available plasmids (Fig. 6A)43. The hpo template 
phpo::hpo-10xGly-HAT-3xFLAG, containing the HP1 gene (hpo) fused to a 10-glycine 
tail linker, a histidine affinity tag (HAT), and the 3-FLAG affinity tag (3xFLAG), all 
under the control of the endogenous HP1 promoter (phpo), was inserted between the 
NotI and ApaI restrictions sites of pBSK. I used this construct as a template to generate 
all hpo mutants listed in Table 1. 
The following protocol was derived from the QuikChange™ Site-Directed 
Mutagenesis Kit from Stratagene. For each desired mutation, 2 single-primer PCR 
reactions were set up in parallel using complementary primers with the appropriate 
mismatch (Tables 1 and S1). The reaction mix contained 25 ng of the template plasmid, 
10 pmol of primer, 0.5 mM dNTPs, and 2 units of Phusion DNA Polymerase (Thermo 
Fischer Scientific) in a 50 μl volume of 1x Phusion HF buffer. The single primer 
reactions were carried out under the following conditions in a T300 thermocycler 
(Biometra): initial denaturation at 98 °C for 30 seconds, followed by 4 cycles of 98 °C 
for 10 seconds, 60 °C for 1 minute, and 72 °C for 12 minutes, then a final extension at 
72 °C for an additional 7 minutes. Then, I combined 25 μl of product from each of the 
complementary reactions in a single tube with an additional unit of Phusion DNA 
polymerase. Another 18 cycles were conducted as before, but with an annealing 




Following the PCR reaction, I added 10 units of the DpnI endonuclease (New 
England Biolabs) and incubated at 37 °C for 4 hours. DpnI digests the Dam-methylated 
parental strands, but leaves the unmethylated mutant copies intact. Mutagenized 
plasmids were purified with the MinElute PCR Purification Kit (Qiagen) and eluted in 
15 μl of water in accordance with the manufacturer's protocol. 
 
Transformation into DH5α E. coli 
For each reaction, 5 μl of purified PCR product was added to 50 μl of 
chemically competent DH5α Escherichia coli (New England Biolabs). The mixture was 
incubated on ice for 20 minutes, then heat shocked at 42 °C for 1 minute and allowed to 
recover in 1 ml SOC medium at 37 °C for 1 hour. Transformed cultures were 
Table 1. Site-directed mutagenesis 
Mutation Suspected PTM Effect of Mutation 
K104R Acetylation, Methylation, Formylation Prevents acetylation 
K104Q Acetylation, Methylation, Formylation Mimics hyperacetylation 
K124L Acetylation, Formylation Prevents acetylation and formylation 
K124R Acetylation, Formylation Prevents acetylation 
K124Q Acetylation, Formylation Mimics hyperacetylation 
Y126F Phosphorylation Prevents phosphorylation 
T128A Phosphorylation Prevents phosphorylation 
K129L Formylation Prevents formylation 
K169R Acetylation Prevents acetylation 
K169Q Acetylation Mimics hyperacetylation 
K189L Formylation Prevents formylation 
K212L Formylation Prevents formylation 
Y233F Phosphorylation Prevents phosphorylation 
K234L Methylation, Formylation Prevents methylation and formylation 
S263A Phosphorylation Prevents phosphorylation 
List of PTM-site substitutions generated by PCR site-directed mutagenesis and 




centrifuged at 5,000 rpm for 3 minutes, excess medium was discarded, and the 
resuspended concentrate was spread on agar plates with LB medium (LB agar) and 
ampicillin. The plates were grown overnight at 37 °C. 
The next day, I picked 3-5 colonies from each plate and used them to inoculate 5 
mL cultures of LB broth with ampicillin. The liquid cultures were grown overnight with 
constant agitation at 37 °C. Plasmids were isolated from the liquid cultures using the 
QIAprep Spin Miniprep Kit following the manufacturer's instructions (Qiagen). Sanger 
sequencing was used to confirm the presence of desired mutations. To achieve full 
sequencing coverage of the gene, each plasmid was sequenced with 2 separate primers: 
one annealing 82 base pairs upstream of the hpo start codon (Primer 4539, Table SI), 
and the other at nucleotide 450 of the coding sequence (HP1(+450)_seq_Fwd, Table 
S1). Sequencing was performed at the Sequetech facility (Mountain View, CA). In 
addition to the planned mutants, a double-mutated K189L, K212L construct was 
detected in one of the cultures transformed with the products of the K212L reaction. 
This unexpected mutant was processed and analyzed with the others. 
Recloning  
To facilitate recombination into the Neurospora genome at the his-3 locus, the 
mutagenized phpo::hpo-10xGly-HAT-3xFLAG was recloned into the his-3-targeting 
pBM61 vector (Fig. 6B, pBM61 from FGSC)38. To this end, the inserts were excised 
from pBSK by NotI-HF and PacI (both from New England Biolabs). All enzyme 
reactions in this study were performed under the manufacturer's recommended 
conditions unless otherwise specified. The pBM61 vector was liberated from the WT 




against self-ligation and exclusion of the insert, I used Antarctic Phosphatase (New 
England Biolabs) to dephosphorylate the 5' ends of the vector. Inserts and vector were 
isolated from the restriction products by electrophoretic gel purification with the 
MinElute Gel Extraction Kit (Qiagen).  
Ligation was performed with 50 ng of vector, 34 ng of insert, and 400 units of 
T4 DNA ligase (New England Biolabs) in a 15 μl reaction volume with the appropriate 
buffer. After 16 hour incubation at 16 °C, the enzyme was denatured at 75 °C for 15 
minutes. 5 μl of the ligase reaction was used for transformation of DH5α as described 
above. 3-5 colonies were picked from the LB agar ampicillin plate, then DNA was 
isolated from the liquid cultures and analyzed by Sanger sequencing to confirm the 
expected genotype as before. 
Transformation into Neurospora 
To facilitate recombination, constructs were linearized with DraI, and the 
smaller fragment, containing the hpo insert (5'Δhis-3::phpo::hpo-10xGly-HAT-
3xFLAG), was isolated by gel electrophoresis and purified with the MinElute Gel 
Extraction Kit (Qiagen). An aliquot of plasmid p2905 was also processed in this 
manner, producing a WT hpo insert to be used as a control in later experiments. As 
previously described in the Introduction, the linearized sequences were inserted into the 
his-3 locus of the N5580 strain (mat a his-3; Δhpo::hph) by electroporation and 
subsequent homologous recombination (Figures 5 and 6C)38. To facilitate selection of 
the correct progeny, transformed conidia were plated on agar containing Vogel's 
Medium N and sorbose (FGS Vogel's, Table S3) without supplemental histidine, then 




selected and tested for correct integration by restriction digest and Southern analysis. I 
confirmed the ectopic expression of HP1 by western blotting (as described below). 
Strains, Growth Conditions, and Crosses 
All Neurospora strains used in this study are listed in Table S2. Recipes for 
media and buffers are listed in Table S3. Strains were grown, maintained, and crossed 
by conventional methods under standard conditions, which are detailed in past 
publications44–46. Primary transformants with proper genotype and confirmed ectopic 
expression of HP1 were crossed with the N4890 strain (mat A his-3; CenVIR::bar trp-2) 
to generate progeny that could be assessed for centromeric silencing by testing 
resistance to Basta (Fig. 6D)21. Crosses were performed on SC agar crossing medium 
using the primary transformants as the female strains. Progeny were grown on FGS 
Vogel's with hygromycin and tryptophan in the absence of histidine to select for the 
his-3+-linked hpo construct and the knockout of endogenous hpo (Δhpo::hph). 
Southern Analysis of Genotype and DNA Methylation 
Progeny retaining the CenVIR::bar marker were identified by Southern analysis 
of genomic DNA samples digested with BamHI and visualized with a bar probe. 
Correct integration of the hpo construct was verified by Southern analysis of an EcoRI 
genomic digest using a his-3 probe38,47. Similarly, I assessed DNA methylation by 
digesting DNA samples with 5mC-insensitive DpnII, or its 5mC-sensitive isoschizomer 
BfuCI, which leaves cytosine-methylated restriction sites intact (Fig. 6F). Southern 
hybridization with various probes was used to visualize the degree of fragmentation and 




be analyzed were grown for 2 days under constant agitation at 32 °C in 5 mL of Vogel's 
medium N with 1.5% sucrose and required supplements. The methods for isolation of 
genomic DNA and Southern hybridization were consistent with previous 
research39,44,49,50. Probes were made by PCR of genomic DNA with the primers listed in 
Table S1. Restriction digests for Southern blots were performed overnight at 37 °C with 
1 μg of genomic DNA and 10 units of the indicated enzyme in 15 μl of the respective 
buffer. 
Western Blotting to Detect Ectopic HP1 Expression 
Strains were grown for 16 hours under the same conditions used for genomic 
DNA cultures. Mycelium was collected by vacuum filtration, and excess moisture was 
removed by blotting with paper towels. Each sample was frozen in liquid N2 and 
suspended in a volume of ice-cold lysis buffer roughly proportional to its mass 
(~ 9 μl/mg). Lysis was induced using a sonicator (Branson Sonifier-450) at a duty cycle 
of 80 with output set to 2 for three 20 second intervals interspersed by 10 minute 
periods on ice. Cell debris was pelleted by centrifugation at 14,000 rpm for 5 minutes at 
5 °C. The supernatant was mixed with an equal volume of 2x Laemmli buffer, heated at 
95 °C for 5 minutes, and reduced with 1% DTT added after heating. 
Supernatants were loaded onto either 10% or 12% polyacrylamide gels and 
analyzed by SDS-PAGE followed by western blotting on polyvinylidene difluoride 
(PVDF) membranes as described previously22. Membranes were blocked with 3% (w/v) 
skim milk powder in TBS-T solution to prevent antibodies from binding the membrane 
in a nonspecific manner. After blocking, membranes were treated overnight with a 




HRP, Sigma) in TBS-T with 1% milk at 4 °C. Membranes were washed 3 times for 10 
minutes with TBS-T solution and developed with SuperSignal West Pico 
chemiluminescence substrate (Thermo Fischer Scientific) according to the 
manufacturer's instructions. Images were captured with the Odyssey FC Imaging system 
(LI-COR) on the 700 nm chemiluminescence channel. 
To control for protein loading, membranes were subsequently stained for 
phosphoglycerate kinase 1 (PGK1). First, peroxidase was inactivated by freezing the 
membrane and incubating with 1% NaN3, 1% (w/v) skim milk powder in TBS-T 
washing buffer for 1 hour at room temperature. The blots were probed with a 1:5,000 
dilution of rabbit polyclonal antibody for PGK1 (kindly provided by Stevens Lab, 
University of Oregon) in TBS-T with 1% (w/v) skim milk powder. Blots were washed 
and incubated with goat anti-rabbit-HRP diluted from a 10,000x stock in the same 
washing buffer, then developed and visualized as described above. 
Assessment of Centromeric Silencing by Spot Testing for Basta Resistance 
Expression of the CenVIR::bar marker was determined by spotting serial 
dilutions of conidia on plates with varying concentration of Basta (Bayer Cropscience, 
Fig. 6E). Conidial suspensions were quantified with a hemocytometer and standardized 
to have 105 conidia per 3 μl spot (3.3 x 104 conidia per μl). Standardized stocks were 
used to make three 1:10 serial dilutions. 3 μl drops from each suspension were spotted 
on Basta medium with varying concentrations of the drug. Plates of this medium were 
prepared with no drug, 1x Basta (8 mg/ml), 1.5x Basta (12 mg/ml), and 2x Basta (16 
mg/ml, data not shown). Plates were imaged with a Molecular Imager Gel Doc XR 





Figure 6: Schematic of Experimental Design 
A) PCR site-directed mutagenesis was used to generate the desired amino acid 
substitutions in a small plasmid (pBSK) carrying the hpo construct. B) The hpo insert 
was excised from the pBSK vector and ligated into the pBM61 backbone of p2905 just 
downstream of the 5'-truncated his-3-gene. C) Constructs were linearized with and 
transformed into the N5580 Neurospora strain, in which the endogenous hpo had been 
replaced with the hph drug resistance gene. D) Primary transformants were crossed 
with the N4890 strain to produce homokaryotic progeny with the bar gene inserted into 
the pericentric heterochromatin of LGVI. E) Expression of the CenVIR::bar marker 
was used to assess centromeric silencing, as determined by growth on medium 
containing Basta-containing medium. F) Southern hybridizations of genomic DNA 
digested with a 5mC-sensitive enzyme were probed for various regions of the genome 







We explored the functional role of several suspected PTMs of HP1 using a site-directed 
mutational analysis. I generated 17 FLAG-tagged hpo constructs with mutations at 11 
suspected PTM sites under the control of the endogenous promoter (Table 2). All 17 
constructs were inserted at the his-3 locus of an hpo knockout Neurospora strain 
(N5580) in an effort to test their rescue of the Δhpo phenotype and compare it to the 
WT HP1 phenotype. At present, transformants carrying 7 of these constructs have been 
crossed to give progeny with the CenVIR::bar marker and the desired construct. I was 
successful in engineering strains with ectopic expression of mutant HP1 in a Δhpo; 
CenVIR::bar background, but most of these constructs have only been verified and 
Table 2. Generation and Testing of Strains with Substitutions in 
Ectopic hpo 
Construct Integrated at 
his-3 in N5580 
CenVIR::bar 
progeny isolated 
5mc and centromeric 
silencing tested 
hpoWT yes 1 yes 
hpoK104R yes 0 no 
hpoK104Q yes 0 no 
hpoK124L yes 0 no 
hpoK124R yes 0 no 
hpoK124Q yes 0 no 
hpoY126F yes 0 no 
hpoT128A yes 0 no 
hpoK129L yes 0 no 
hpoK169R yes 1 yes 
hpoK169Q yes 1 yes 
hpoK189L yes 1 yes 
hpoK212L yes 2 yes 
hpoK189L, K212L yes 1 yes 
hpoY233F yes 0 no 
hpoK234L yes 0 no 





assessed in a single strain. Replication of the results in a larger number of progeny is 
currently underway, and I am also working to complete the screening and 
characterization of the untested mutants. 
Partial Loss of HP1-Mediated Centromeric Silencing in Strains with Substitutions 
at Certain PTM-Sites 
To determine whether PTMs play a role in HP1-dependent centromeric 
silencing, I analyzed expression of the centromeric bar marker (CenVIR::bar) in each 
of the mutant strains. Resistance to Basta was compared to control strains with normal 
centromeric silencing or with known defects in silencing. Control strains with 
knockouts of hpo (N4891) or hda-1 (N4906) displayed growth on Basta at both of the 
concentrations tested (Fig. 7). As an additional control, I used a strain with 
his-3::hpoT108A (N5891). In previous experiments by my mentor, this mutation was 
found to cause loss of silencing and DNA methylation (T. Ormsby, unpublished). The 
vigorous growth of these controls shows the ability of this assay to reveal defects in 
silencing. In contrast, a strain containing just CenVIR::bar (N4890) was unable to grow 
in the presence of Basta. Multiple control strains carrying the WT hpo construct at his-3 
were also tested. hpoWT-1 (N5889) has the same lineage as hpoT108A, and was also 
generated by my mentor. I produced hpoWT-2 (N6291) by the previously described 
methods. These controls had minimal growth on Basta, indicating rescue of WT 
silencing and negligible disruption from the affinity tags or expression at the non-native 
locus.  
 However, strains with PTM-site substitutions exhibited significant reductions in 




a greater resistance to Basta than any of the hpoWT controls, which is especially evident 
on 1x Basta. Although the mutants had greater growth on Basta relative to the hpoWT 
controls, they have less resistance than the Δhpo, Δhda-1, or hpoT108A controls, and are 
much more sensitive to higher concentrations of the drug (1.5x, 2x not shown). 
While some mutations appeared to have a larger effect than others, the 
differences between mutants were obscured by high variation between sister progeny 
with the same hpo sequence. This variation is evident in the sister hpoK212L strains, 
where hpoK212L-1 has much greater resistance to Basta than hpoK212L-2. The cause of this 
variation is uncertain, as is the true characteristic phenotype caused by this mutation. 
Unexplained variation between sister progeny has also been observed in other hpo 
mutants generated by my mentor (T. Ormsby, unpublished). While it does cause 
difficulty in comparing subtle differences between mutants, high phenotypic variability 
is not unusual for epigenetic effects, and does not necessarily negate the decrease in 
centromeric silencing observed in all of the hpo mutants I examined51. Using the same 
methods, my mentor found no consistent changes in silencing among dozens of 
phosphorylation site mutants (T. Ormsby, unpublished findings). This suggests 
centromeric silencing is sensitive to mutations at only a subset of PTM-sites, and that 
the observed defects may be specifically caused by loss of methylation, formylation, 
and acetylation at the sites I examined, and possibly at additional sites that remain to be 
tested. These results are highly suggestive, but they must be replicated in a larger 
number of progeny before they are conclusive. Results from additional progeny will 





Figure 7: Reduction of Centromeric Silencing in Strains with Substitutions at PTM 
Sites 
Standardized serial dilutions of condial suspensions from strains harboring a 
centromeric bar construct, CenVIR::bar, were spotted on medium containing no drug, 
1x Basta (8 mg/ml), or 1.5x Basta (12 mg/ml). hpoT108A - hpoK234L denote substitutions 
in  phpo::hpo-10xGly-HAT-3xFLAG at the his-3 locus in a Δhpo background. hpoT108A 
and hpoWT-1 were provided by my mentor, Tereza Ormsby. The curved line segment in 
the upper middle panel is a fracture in the agar medium resulting from a handling error. 
From top to bottom, the following strains were used: N5580, N4890, N4891, N5891, 
N5889, N6291, N6292, N6293, N6294, K212L-2, N6296, N6297, K234L.  
Evidence Against a Universal Defect in HP1 Functions 
Loss of centromeric silencing has previously been observed in knockouts of 




the case of hpoT108A, Ormsby et al, unpublished). For proper centromeric silencing to 
occur, HP1 must be stably expressed, correctly folded, imported into the nucleus, 
coupled into homodimers, and properly localized to H3K9me3. Defects in any of these 
processes could be responsible for the observed decreases in silencing, but they would 
also be expected to cause other functional impairments. To discern the true mechanisms 
by which these substitutions disrupt centromeric silencing, we investigated their effects 
on cytosine methylation by Southern analysis. 
First, we examined whether DNA methylation was preserved at the known 
heterochromatin domains 8:A6 and 8:F10 (Fig. 8). Knockout strains for hpo (N5580), 
dmm-1 (N3064), and hda-1 (N3610) were used as controls, along with a WT strain 
(N3752), and the hpoWT-2 strain used in the silencing assay. Consistent with previous 
findings, Δhpo and Δhda-1 caused hypomethylation at 8:A6, as indicated by the absence 
of larger restriction fragments relative to WT. Δdmm-1 produced an opposite effect, 
causing an increased proportion of high mass BfuCI fragments indicative of 
hypermethylation from heterochromatin spreading, as seen previously23. An increase in 
the smallest fragments (0.6 kb) is also visible. This pattern is produced by a 
combination of central hypomethylation and peripheral hypermethylation characteristic 
of DMM mutants. Comparison with these controls will help to differentiate between 
defects in distinct functions of HP1. 
The control strain expressing affinity-tagged WT HP1 at his-3 (hpoWT-2) has 
moderate hypomethylation, which suggests some degree of interference from the 
affinity tags. Incomplete rescue of DNA methylation from the recombinant hpoWT could 




were excluded from the vector. Expression of HP1-FLAG was confirmed by western 
analysis of each strain (data not shown), but we cannot yet compare it to endogenous 
levels of expression because we do not have an antibody for the untagged protein in 
WT. This reduced level of DNA methylation serves as the background against which 
methylation in the hpo mutants will be measured. Relative to this control, the hpoK169Q 
strain exhibits a minor increase in one of the larger fragments (~ 1.8 kb) and in the 
larger of the two smaller fragments (~ 1.2 kb). This may suggest mild 
hypermethylation, although it still exhibits less DNA methylation than the WT strain 
(N3752). A modest reduction in 8:A6 methylation was detected in the hpoK189L strain. 
These small changes may not be significant, and would have to be reproduced in a 
larger number of progeny to prove that they are not the result of variance from other 
factors, as demonstrated by the results of the silencing assay. I found no detectable 
changes in DNA methylation at 8:A6 in the remaining strains. 
Probing for the 8:F10 heterochromatin domain revealed no major differences 
between the N3752 WT, the hpoWT, and the PTM-site substitution strains (Fig. 8B). 
There may be some hypermethylation in hpoK169Q, but if so, it is too subtle to clearly 
discern. It is worth noting that DNA methylation at this locus is generally more robust 
than methylation at 8:A6. It does not require HCHC, as evidenced by the normal DNA 
methylation in the hda-1 knockout. However, 8:F10 methylation does require 
localization of the DIM-2 DNA methyltransferase. Invariant levels of 8:F10 
methylation suggest that the mutations did not disrupt the stability of HP1, its 






Figure 8: Decreased Silencing in PTM-Site Mutants is Not Associated with Consistent 
Changes in DNA Methylation at Known Heterochromatin Domains 
Genomic DNA from N3752, N5580, N3064, N3610, N6291, N6292, N6293, N6294, 
K212L-2, N6296, N6297, and K234L were digested with 5mC-insensitive DpnII (D) or 
its 5mC-sensitive isoschizomer BfuCI (B), then analyzed by Southern hybridization 
with probes for the A) 8:A6, and B) 8:F10 heterochromatin domains. hpoWT-2 - hpoK234L 





Decreased Silencing in PTM-Site Mutants is Not Accompanied by Consistent 
Hypermethylation of Centromeres 
Although no decrease in DNA methylation at 8:A6 was detected, we reasoned 
that partial defects in HCHC activity might disrupt centromeric silencing without 
significantly affecting 8:A6. To explore this possibility, we investigated cytosine 
methylation of the centromeres, which is greater in knockouts of HCHC. Although the 
exact mechanism has not been conclusively established, it has been proposed that 
centromeric hypermethylation in HCHC-deficient strains is an indirect effect mediated 
by changes in chromatin conformation21. To test whether the same effect was present in 
the PTM-site mutants, I examined DNA methylation at two centric loci in linkage 
group 7 (LGVII). 
I detected hypermethylation of CenVIIR in the Δhda-1 control, but this effect 
seemed weaker than has been previously reported in literature, and was visible only as a 
faint smear extending above the major bands (Fig. 9A)21. As with 8:F10, no appreciable 
differences in methylation were apparent between WT and hpoWT-2, indicating that the 
hpo construct essentially rescued DNA methylation at CenVIIR from the Δhpo 
phenotype. Δdmm-1 seemed to produce modest hypomethylation at this locus, reflecting 
its general antagonism with HCHC and its tendency to decrease methylation at the core 
of heterochromatin domains (Honda et al, unpublished)21,23. With the other mutants, no 
definitive changes were seen, but a few subtle differences were observed. In hpoK212L-1 
and hpoK189L, K212L, a slight decrease in the smallest fragment paired with barely 
noticeable increases in the largest two fragments (~ 1.5 kb and 2.2 kb) could indicate 




this change is inconsistent and may be caused by other factors. hpoK234L appears to have 
a slightly more noticeable decrease in methylation at this locus, but care must be taken 
to avoid over-interpretation of this difference, which is relatively small and has not been 
reproduced. 
CenVIIL also sported only minor differences rather than consistent 
hypermethylation in the mutants (Fig. 9B). Here, the absence of hda-1 produced much 
greater hypermethylation than at CenVIIR, which indicates that defects in HCHC should 
be easier to detect at this locus. The loss of dmm-1 produced little change in 
methylation. Rescue of DNA methylation by the hpoWT-2 appears to be slightly 
incomplete, considering that the larger fragments (~ 3 kb and 4.5 kb) are somewhat 
fainter than in WT. Perhaps the only notable changes in DNA methylation at this locus 
were found in hpoK212L-2 and hpoK234L, which presented some degree of 
hypermethylation relative to hpoWT-2 and possibly even to the endogenous WT. This is 
evident in the increased ratio of the middle fragment (~ 3 kb) to the lower fragment 
(~ 2.2 kb). Again, the discrepancy between the sister hpoK212L strains demands caution 
in interpreting these changes, which cannot be directly attributed to the substitutions in 
hpo. Furthermore, hpoK234L exhibited equally significant hypomethylation at CenVIIR, 
so limited hypermethylation at this locus is not necessarily representative of more 






Figure 9: DNA Methylation in the Pericentric Heterochromatin of PTM-Site Mutants 
Genomic DNA from N3752, N5580, N3064, N3610, N6291, N6292, N6293, N6294, 
K212L-2, N6296, N6297, and K234L were digested with 5mC-insensitive DpnII (D) or 
its 5mC-sensitive isoschizomer BfuCI (B), then analyzed by Southern hybridization 
with probes for the A) CenVIIR, and B) CenVIIL pericentric regions. hpoWT-2 - hpoK234L 





Normal Containment of DNA Methylation at Boundaries of Heterochromatin 
Domains in PTM-Site Mutants 
In accordance with our objectives, we also explored the effect of PTM-site 
substitutions on the functionality of the DMM complex. The primary consequence of 
defective DMM is the spreading of heterochromatin (as measured by its epigenetic 
hallmarks) beyond normal heterochromatin domains and into adjacent euchromatin. We 
assessed DNA methylation at a flanking region of the 8:G3 heterochromatin domain. 
This euchromatic border area is known to be hypermethylated in DMM knockouts but 
unmethylated in WT (Fig. 10A)23. This was independently verified by Southern 
analysis, revealing extensive hypermethylation in the Δdmm-1 strain. However, the 
8:G3 boundary remained unmethylated in the other controls and in the hpo mutants. 
While this shows that none of the mutant strains have defects only in DMM, deletion of 
HCHC components is known to prevent methylation spreading in a Δdmm-1 
background (Honda et al, unpublished). 
Lastly, I also probed for the euchromatic cyclosporin A resistance gene (csr-1) 
as a control to check for completion of the digestion reactions (Fig. 10B). Sharp, well-
resolved bands of equal size, position, and intensity in the DpnII and BfuCI products of 







Figure 10: Control of Heterochromatin Spreading is Not Disrupted in Strains With 
Substitutions at Particular PTM-Sites of HP1 
Genomic DNA from N3752, N5580, N3064, N3610, N6291, N6292, N6293, N6294, 
K212L-2, N6296, N6297, and K234L were digested with 5mC-sensitive DpnII (D) or 
its 5mC-sensitive isoschizomer BfuCI (B), then analyzed by Southern hybridization 
with probes for A) the euchromatic flank of the 8:G3 heterochromatin domain, and B) 
the csr-1 euchromatin control region. hpoWT-2 - hpoK234L denote substitutions in  





Specific Requirement of Certain HP1 PTMs for Centromeric Silencing 
I found a substantial loss of centromeric silencing in strains where the K169, 
K189, K212, or K234 PTM-sites of HP1 were substituted with other amino acids to 
prevent (or mimic) modification. While silencing was decreased by mutations at each 
one of these sites, a corresponding decrease in other tested HP1 functions was not 
detected. Rescue of DNA methylation at known heterochromatin domains shows that 
loss of the targeted PTMs does not significantly affect the recruitment of DIM-2 or 
more general HP1 functions like dimerization and localization to H3K9me3. Although 
the results are not yet conclusive, they do support our initial hypothesis that PTMs 
confer functional specialization to HP1 by modulating its interactions with other 
proteins. If these findings are replicated and verified in further experiments, they may 
provide the first evidence that PTMs selectively facilitate distinct HP1 functions in 
Neurospora. However, the mechanism by which these PTMs participate in centromeric 
silencing is currently unclear. In the following sections, I propose two feasible 
mechanisms to be explored in future work. 
Putative Dependency of Mi-2 Activity on PTMs in the Chromoshadow Domain 
HCHC plays a documented role in centromeric silencing, but new work has 
found that the ATP-dependent chromatin remodeler Mi-2 is also recruited by HP1 and 
required for centromeric silencing in Neurospora (Honda et al, manuscript in 
preparation). Accordingly, the partial relief of CenVIR::bar expression observed in the 




HCHC. However, strains deficient in HCHC reliably exhibit hypermethylation at 
centromeric loci and loss of DNA methylation at some other heterochromatin domains, 
including 8:A621. These effects were clearly detected by Southern analysis of the 
Δhda-1 control, but are not visible in the PTM-site mutants with faulty silencing. The 
pattern of DNA methylation in these mutants is inconsistent with a mechanism that only 
affects HCHC activity. 
By comparison, knockouts of mi-2 display normal levels of DNA methylation at 
centromeric loci, and only a minor decrease of DNA methylation at 8:A6, rather than a 
total loss of it. In addition, Δmi-2 strains appear to have slightly lower expression of 
CenVIR::bar than those with loss of HCHC components (Honda et al, manuscript in 
preparation), possibly explaining why the PTM-site mutants were less resistant to Basta 
than the Δhpo and Δhda-1 controls. Because the Mi-2 findings were brought to our 
attention after the completion of the experiments in this study, Δmi-2 Neurospora was 
not included as an experimental control for direct comparison with the mutants. Despite 
this omission, the observed phenotypes of the PTM-site mutants are in good agreement 
with the reported phenotypes of mi-2 knockouts, although the incomplete relief of 
CenVIR::bar expression suggests the loss of Mi-2 activity may be only partial. 
Furthermore, the forthcoming publication by Honda et al found that HP1 interacts with 
Mi-2 through its chromoshadow domain, which contains 2 of the 4 sites investigated 
(K234 and K212). The other two PTM sites (K189 and K169) are just outside the 
chromoshadow domain in the adjacent periphery of the hinge region, where they could 
plausibly exert an effect on the interaction (Fig. 3). Together, the results indicate that 




and that the absence of these PTMs disrupts the function of the complex between these 
proteins. 
Defects in HCHC Activity  
Although a defect in Mi-2 activity is sufficient to explain the phenotype 
observed in the PTM-site mutants, other explanations are also possible, and cannot yet 
be excluded from consideration. In particular, it is possible that the decrease in 
centromeric silencing was caused by a defect in HCHC activity that did not produce the 
characteristic changes in DNA methylation. Although this has not been observed in past 
studies, there are at least two feasible ways by which relatively normal levels of DNA 
methylation could have been maintained in strains with HCHC deficiency21. 
Tiered Phenotype Effects in Strains with Partial Loss of HCHC 
Defective HCHC causes loss of centromeric silencing, centromeric 
hypermethylation, and hypomethylation at some heterochromatin domains (8:A6), but 
these effects may be induced at different thresholds. Relatively minor defects in the 
recruitment or activation of HCHC could cause detectable decreases in silencing like 
those seen in the PTM-site mutants, but changes in DNA methylation might occur only 
when HCHC is severely defective. The mechanism of centromeric hypermethylation in 
HCHC-deficient strains remains undetermined, but the leading hypothesis contends that 
histone hyperacetylation causes a relaxation of chromatin conformation and thereby 
increases its accessibility to the DIM-2 DNA methyltransferase21. The PTM-site 
mutants have only partial loss of centromeric silencing, indicating that some degree of 




conformation of centromeric chromatin that was just sufficient to express CenVIR::bar 
at modest levels, but not enough to substantially increase its accessibility to DIM-2. If a 
similar mechanism is responsible for other changes in the methylation profile of HCHC 
knockouts, then these changes may be similarly absent in strains where defects in 
HCHC are only moderate. 
Concomitant Antagonistic Defects in HCHC and DMM 
Another way in which typical indicators of HCHC function could possibly be 
concealed is through antagonism between the HCHC complex and the DMM complex. 
While cytosine methylation spreading was not detected at the 8:G3 heterochromatin 
boundary in any of the PTM mutants, loss of HCHC has been shown to prevent 
heterochromatin spreading in a Δdmm-1 background (Honda et al, unpublished). If the 
examined PTMs are required for both the function of the DMM complex and the HCHC 
complex, the loss of DMM function in the PTM-site mutants would not induce cytosine 
methylation spreading at 8:G3, because spreading cannot occur in the absence of 
HCHC. 
In this case, the effects of DMM deficiency on the HCHC phenotype must also 
be considered. While such interactions have not been thoroughly explored by 
experimental means at the time of this writing, the antagonistic functions of HCHC and 
DMM may be a two-way relationship rather than a unidirectional pathway. Such a 
scenario can easily be imagined through a comparison of their disparate phenotypes. 
Whereas HCHC knockouts cause centromeric hypermethylation, DMM knockouts tend 
to cause hypomethylation at the interior of centromeres, although this effect is not 




cause major hypomethylation at 8:A6, Δdmm-1 produced marked hypermethylation 
(Fig. 8A). For many regions of the genome, including those analyzed by Southern 
blotting in this study, it is feasible that these antagonistic effects may roughly cancel 
out, perhaps contributing to phenotypic instability and high variation between progeny. 
Because of this, it is entirely possible that the PTM mutants have dual reductions in the 
activity of both complexes. 
Other Possible Causes of Mutant Phenotypes 
Rather than promoting the recruitment of HP1 binding partners, the PTMs under 
investigation could confer functional specialization by inhibiting specific interactions 
with other proteins. Such a mechanism could conceivably be responsible for the 
preferential localization of the DMM complex to the periphery of heterochromatin 
domains, preventing it from antagonizing heterochromatin establishment at the interior 
of centromeres. Eliminating such a modification might cause a loss of centromeric 
silencing like that detected in this study, although the effects on DNA methylation may 
or may not match the observed phenotypes. 
Alternatively, it is possible that currently unknown chromatin-associated factors 
or signaling proteins interact with HP1 to facilitate other important functions, which 
may feed back into the known heterochromatin pathways. This possibility is supported 
by the recent discovery of Mi-2's functionally significant interaction with HP1 (Honda 
et al, unpublished). Similar interactions with other chromatin modifiers or remodelers 
may be awaiting discovery. Equally suggestive is the extensive modification of HP1 by 
unidentified enzymes in response to unknown signals. It is both plausible and likely that 




where information from multiple pathways is stored. Substitutions at a given PTM-site 
may affect the modification of other sites. As an example, the recruitment of Mi-2 
might be directly controlled solely by acetylation of K169. However, the lysine acetyl-
transferase responsible for acetylation of this site might be active only if K189, K212, 
and K234 are formylated. In this way, a particular function of HP1 may be directly 
mediated by only a single PTM, but indirectly regulated by a larger network of PTMs 
with linked functions. Characterizing PTM mutants with substitutions at multiple sites 
will help to address this possibility. 
It is also worth noting that strains with hpoK169R and hpoK169Q both exhibited a 
similarly substantial decrease in silencing. If arginine substitution mimics a loss of 
acetylation and glutamine substitution mimics constitutive acetylation, these 
substitutions should have opposite effects, and normal silencing should be seen in one 
of the two strains. The deviation from this expectation likely indicates that glutamine 
substitution did not truly mimic constitutive acetylation. Even though the charge of this 
residue is similar to that of acetyl-lysine, the structure may be sufficiently different to 
disrupt any interactions that depend on lysine acetylation. 
Many of the proposed mechanisms are somewhat speculative, but the evidence 
gathered in this study is not sufficient to disprove them. The proposed dependence of 
Mi-2 recruitment on PTMs in the chromoshadow domain is by far the simplest, most 
direct, and most likely explanation for the results of this study. However, the large 
number of alternative plausible alternative mechanisms demonstrates the need for 





The largest limitation of this project as it currently stands is the lack of multiple 
replicates for each of the mutant strains. Previous studies have established that even 
clonally related strains propagated from individual conidia of a single parent have stable 
differences in their levels of gene expression and DNA methylation51. Background 
phenotypic variation between strains introduced considerable uncertainty into the 
results. While this does not undermine the significance of the decrease in centromeric 
silencing observed in all of the mutants, it does make it much more difficult to compare 
subtle differences between them. To eliminate any differences caused by ectopic 
expression at the his-3 locus, each construct will be inserted at the endogenous hpo 
locus, and multiple transformants carrying each mutation will be characterized. This 
will make it possible to overcome the variation and to establish a representative 
phenotype for each mutation. In addition, I will characterize the remaining mutant 
strains that have not yet been tested. 
Future research will also explore the possible mechanisms responsible for these 
phenotype effects. To ascertain whether the observed defects in silencing are caused by 
decreased activity of Mi-2 or HCHC, the endogenous hpo mutants will be crossed into a 
Δdmm-1 background. If the hpo substitutions inhibit HCHC activity, they should 
eliminate DNA methylation spreading at 8:G3 in a Δdmm-1 background. If a reduction 
in Mi-2 activity is responsible for the silencing defects, spreading at 8:G3 will persist in 
the Δdmm-1 PTM mutant progeny. 
To verify the results of this experiment, I will test heterochromatin silencing at 




preparation). This will be tested by assessing the silencing of a bar marker that has been 
inserted between RIP'd duplicate copies of his-3 (his-3RIP::bar). Progeny carrying this 
marker and the desired substitutions in endogenous hpo will be isolated from an 
appropriate cross and spot tested on Basta. Basta resistance would suggest loss of 
HCHC activity, and silencing would indicate loss of Mi-2 function. Knockout of mi-2 is 
also known to cause DNA methylation spreading at characteristic sites that are 
unmethylated in WT, Δdmm-1, or Δhda-1. Probing for these regions in a methylation-
sensitive Southern analysis will provide additional support for the results of the other 
assays. 
In addition, I will use co-immunoprecipitation to directly measure changes in 
affinity between the mutated HP1 protein and Mi-2 or CDP-2, which is the direct 
interacting partner of HP1 in the HCHC complex21. If the Mi-2 mechanism is correct, I 
should detect decreased affinity of the mutagenized HP1 protein for Mi-2 without a 
corresponding decrease in its affinity for CDP-2. Conversely, a selective decrease in the 
affinity for CDP-2 would support a mechanism mediated by HCHC. It is also possible 
that the substitutions inhibit the activity of Mi-2 or HCHC without disrupting their 
recruitment by HP1, in which case no decrease in affinity would be expected. In 
conjunction with the experiments mentioned above, this method will expose differences 
between the existing hypotheses and provide more conclusive evidence for the 
mechanism of PTM-dependent centromeric silencing. 
Another question I aim to answer in future work is whether mutation of multiple 
sites at the same time will lead to different phenotypes. While centromeric silencing, 




modifications, other interactions might be regulated by specific combinations of PTMs 
that are not active individually. To account for this possibility, we will use antibodies 
for epitope-tagged Mi-2, CDP-2, DMM-1, and DIM-2 to pull down each of the known 
HP1 complexes by CoIP. We will then affinity purify HP1 from each of these 
individual complexes and identify the characteristic PTM "fingerprints" by mass-
spectrometry. To eliminate the need for affinity tags and the interference they may 
introduce, I am currently working to purify a polyclonal rabbit antibody against HP1 for 
affinity purification of the native untagged protein. The findings of this study suggest 
that PTMs at K169, K189, K212, and K234 may be preferentially found in HP1 purified 
from the Mi-2 complex. Such a result would demonstrate that PTMs are not only 
capable of regulating HP1 interactions, but that they are regularly used for this purpose 
in WT Neurospora. In addition, combinations of other differentially incorporated PTMs 
might also be identified in other complexes. 
Conclusion 
In furtherance of our initial hypothesis, this study successfully identified a 
subset of HP1 PTM sites that are specifically required for centromeric silencing, but not 
for other HP1-dependent functions. The existence of an "HP1 subcode" has long been 
speculated, but this study provides the first evidence for such a code in Neurospora25,26. 
The findings show that PTMs can be used to facilitate functional diversification in HP1, 
enabling local control of its activity. While a number of less direct explanations cannot 
be ruled out at this time, the observed phenotypes are entirely consistent with a specific 
decrease in the recruitment of Mi-2. Future work will seek to replicate these results with 




mechanism of these effects. Further research will also be aimed at identifying PTMs 
with different frequencies in distinct HP1 complexes, which would be likely regulators 
of HP1 function. 
A comprehensive understanding of PTM effects on HP1 function will help to 
elucidate the relationship between the major chromatin modifier complexes. This 
understanding could lay the foundation for the identification and characterization of the 
upstream enzymes that modify HP1, and for research into the regulation of their own 
activity. This study brings us closer to understanding how these regulatory pathways fit 
into a larger network of epigenetic regulation that connects dynamic states of chromatin 
to shifting environmental conditions and perhaps to signaling between cells. Ultimately, 
this knowledge could help to identify targets for drugs that treat the abnormal patterns 






Supplementary Table S1.  Primers used in this study 
Primer Sequence 















































































































Supplementary Table S2. Neurospora crassa strains used in this study 
Strain Genotype Reference 
N3064 mat A his-3; ∆dmm-1::hph+ Honda et al (2010) 
N3610 mat A his-3; ∆hda-1::hph+ FGSC #12003 
N3752 mat A 2489 
N4890 mat A his-3; CenVIR::bar trp-2 Honda et al (2012) 
N4891 mat a his-3; CenVIR::bar hpo Honda et al (2012) 
N4906 mat a his-3; CenVIR::bar trp-2; ∆hda-1::hph+ Honda et al (2012) 
N5580 mat a his-3; Δhpo::hph+ Ormsby et al (unpublished) 
N5889 mat a his-3
+::phpo::hpoWT-10xGly-HAT-3xFLAG; 
CenVIR::bar trp-2 Δhpo::hph+ 
Ormsby et al 
(unpublished) 
N5891 mat a his-3
+::phpo::hpoT108A-10xGly-HAT-
3xFLAG; CenVIR::bar trp-2 Δhpo::hph+ 
Ormsby et al 
(unpublished) 
N6291 mat ? his-3
+::phpo::hpoWT-10xGly-HAT-3xFLAG; 
CenVIR::bar trp-2 Δhpo::hph+ This study 
N6292 mat ? his-3
+::phpo::hpoK169Q-10xGly-HAT-
3xFLAG; CenVIR::bar trp-2 Δhpo::hph+ This study 
N6293 mat ? his-3
+::phpo::hpoK189L-10xGly-HAT-
3xFLAG; CenVIR::bar trp-2 Δhpo::hph+ This study 
N6294 mat ? his-3
+::phpo::hpoK212L-10xGly-HAT-
3xFLAG; CenVIR::bar trp-2 Δhpo::hph+ This study 
N6296 mat ? his-3
+::phpo::hpoK169R-10xGly-HAT-
3xFLAG; CenVIR::bar trp-2 Δhpo::hph+ This study 
N6297 mat ? his-3
+::phpo::hpoK189L, K212L-10xGly-HAT-
3xFLAG; CenVIR::bar trp-2 Δhpo::hph+ This study 
K212L-2 mat ? his-3
+::phpo::hpoK212L-10xGly-HAT-
3xFLAG; CenVIR::bar trp-2 Δhpo::hph+ This study 
K234L mat ? his-3
+::phpo::hpoK234L-10xGly-HAT-






Supplementary Table S3.  Recipes used in this study 
Mixture Composition 
Bacterial growth media 
LB broth 1% tryptone, 1% NaCl, 0.5% yeast extract 
  
LB agar 1.5% agar, 1% tryptone, 1% NaCl, 0.5% yeast extract 
  
SOC medium 2% tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgSO4, 20 mM glucose 
  
Neurospora growth media 
Vogel's trace element 
solution 
5 g Na3Citrate·1 H2O, 5 g ZnSO4·7 H2O, 
1 g (NH4)2Fe(SO4)2·6 H2O, 250 mg CuSO4·5 H2O, 
50 mg MnSO4·1 H2O, 50 mg H3BO3, 50 mg 
Na2MoO4·2 H2O, 100 ml final volume in water 
  
Biotin solution 50% ethanol, 50 μg/ml biotin 
  
50x Vogel's medium N 
150 g Na3Citrate·5 H2O, 250 g KH2PO4, 100 g NH4NO3, 
10 g MgSO4·7 H2O, 5 g CaCl2·2 H2O, 5mL biotin 
solution (50 μg/ml), 5 ml trace element solution, 1 liter 
final volume in water 
  
50x Synthetic crossing 
medium (SC) 
250 g KH2PO4, 150 g Na3Citrate·5 H2O, 10 g NH4NO3, 
10 g MgSO4·7 H2O, 5 g CaCl2·2 H2O, 5mL biotin 
solution (50 μg/ml), 5 ml trace element solution, 1 liter 
final volume in water 
  
FGS Vogel's agar 
(Colonial growth) 
1.5% agar, 1x Vogel's medium N, 2% sorbose, 
0.05% fructose, 0.05% glucose 
  
SC agar (crossing 
medium)  




1.5% agar, 1x nitrogen-free Vogel's medium 
(no NH4NO3), 2% sorbose, 0.5% proline, 0.05% fructose, 
0.05% glucose, desired concentration of Basta 
  
Western blotting buffers 
Lysis buffer 
10% glycerol, 150 mM NaCl, 50 mM HEPES pH 7.5, 
10 mM EDTA, 0.02% NP40, EDTA-Free Complete Mini 







2x Laemmli buffer 20% glycerol, 4% SDS, 125 mM Tris (pH 6.8), 0.02% bromophenol blue 
  
TBS-T 10 mM Tris (pH 7.5), 150 mM NaCl, 0.05% Tween 20 
  
Concentrations of Drugs and Supplements 
Ampicillin 100 μg/ml (1x) diluted from 100 mg/ml stock (1000x) 
  
Hygromycin 2 μg/ml (1x) diluted from 1 mg/ml stock (500x) 
  
Basta 8 mg/ml (1x) diluted from 400 mg/ml stock (50x) 
  
Histidine 500 μg/ml (1x) diluted from 25 mg/ml stock (50x) 
  









3' and 5': The two opposite ends of a DNA stand, which are used to establish 
directionality. On the coding strand of DNA, the start of a gene will be towards the 
5' end relative to the end of a gene, which is closer to the 3' end.  
 
Acetylation: The covalent addition of an acetyl group to a substrate. An acetyl 
group contains two carbons, one of which is a methyl group, and the other of 
which is bound to the substrate and double bonded to oxygen. This addition can 
change the physical and chemical properties of the target molecule. 
 
Activation: This can refer to an increase in the level of gene expression, or an 
increase in the activity of the protein product. 
 
Affinity: The strength of intermolecular interactions between a protein and its 
binding partner.  
 
Affinity tag: A polypeptide sequence with high affinity for a specific ligand or 
antibody. Proteins are expressed with affinity tags so they can be easily purified 
with immobilized ligand or visualized with labeled antibodies. 
 
Antibody: A protein generated by immune cells that binds a target protein or 
affinity tag with high specificity. By fluorescently or radioactively labeling and 
antibody, it is possible to visualize the target protein. 
 
Basta: An herbicide, also known as glufosinate, that is lethal to wild type 
Neurospora. Resistance to Basta is conferred by the bar gene. 
 
Centromere: The central part of a chromosome that links identical chromosome 
copies (sister chromatids). The centromere is composed of heterochromatin. 
 
CenVIR::bar: A Basta resistance gene that has been inserted into the pericentric 
region of the right arm of chromosome six. 
 
ChIP-Seq: Chromatin immunoprecipitation sequencing, a method used to map 
interactions between DNA and a protein of interest. ChIP-Seq quantifies the level 
of protein binding across the genome. 
 
Chromatin:  The complex of DNA, histone proteins, and other DNA-associated 
factors in the nucleus. 
 
Chromodomain:  A conserved protein domain that mediates binding to chromatin. 






Chromoshadow domain: The structural domain of HP1 that mediates dimerization 
and interactions with other proteins such as DIM-2. HP1 functions as a 
homodimer. 
 
Chromosome:  Large bundles of chromatin inside the nucleus. The genomes of 
most eukaryotes are divided into a number of chromosomes. The chromosome 
structure helps to preserve the genome and to facilitate segregation during 
mitosis. Neurospora has seven chromosomes. 
 
Cloning: The process by which DNA from multiple sources can be combined in a 
single DNA molecule. Inserting a gene or DNA sequence into a bacterial plasmid is 
a common form of cloning. If recombinant DNA is taken through further stages of 
cloning, it is often referred to as recloning. 
 
Complex: Any group of proteins or other macromolecules that physically interact 
to form a single structure. 
 
Conidia: Asexual, haploid vegetative spores. 
 
DCDC: A five-member complex containing DIM-5, DIM-7, DIM-9, CUL4, and DDB1. 
DCDC generates H3K9me3 through the methyltransferase activity of DIM-5 after 
the complex localizes to A:T-rich DNA, possibly through DIM-7. 
 
DIM (Defective in DNA Methylation): This can refer to a mutant strain of 
Neurospora, a gene required for normal DNA methylation, or the protein product 
of a gene required for DNA methylation.  
 
DIM-2: A DNA methyltransferase responsible for all known DNA methylation in 
Neurospora. HP1 is required for the proper localization of DIM-2 
 
DMM complex: The DNA methylation modulator complex containing HP1, DMM-1, 
and DMM-2. This complex prevents the aberrant spreading of DNA and H3K9 
methylation beyond the boundaries of heterochromatic regions. The exact 
mechanism is not known, but it has been suggested that DMM-1 may act as a 
histone demethylase. 
 
DNA methylation:  An epigenetic marker associated with silencing and 
heterochromatin in eukaryotes. Methylated DNA is characterized by the presence 
of a methyl group attached to cytosine at the carbon-5 position. 
 
Electroporation: The use of a small electric current to make cells more permeable, 







Epigenetics:  The study of heritable or semi-heritable changes in gene expression 
that are not caused by the DNA sequence alone. 
 
Euchromatin: Loosely packed, transcriptionally active chromatin. 
 
Eukaryote: An organism composed of cells with a nucleus and other membrane 
subcompartments. 
 
Gel electrophoresis:  The use of an electric current to drive macromelecules such 
as proteins and DNA through pores in a gel, causing them to separate by size and 
charge.  
 
Gene expression:  The rate at which a gene is transcribed and translated into a 
functional protein product. A gene cannot be active if it is not expressed. 
 
Genome:  The full DNA sequence of an organism. 
 
H3K9: Lysine nine of histone H3. This amino acid can be trimethylated to give 
H3K9me3, which is a heterochromatin hallmark associated with silencing. It can 
also be acetylated to give H3K9Ac, which favors the formation of euchromatin and 
the activation of local genes. 
 
HCHC complex: A protein complex containing HP1, chromodomain protein-2 
(CDP-2), histone deacetylase-1 (HDA-1), and CHAP. This complex localizes to 
H3K9me3 and deacetylates adjacent H3K9. This process is essential for 
centromeric silencing. 
 
Heterochromatin: Densely packed chromatin with minimal transcription. 
Heterochromatin performs many important functions involved in the structural 
integrity of chromosomes and in gene regulation. 
 
his-3: One of the genes required for the synthesis histidine in Neurospora. The his-3 
locus is a common target for transformation. 
 
Histone:  A family of proteins that interact with DNA to form chromatin. Histones 
H2A, H2B, H3, and H4 form the protein core of the nucleosome.  Modifications of 
histone H3 play an important role in regulating gene expression. 
 
Homodimer: A protein complex containing two identical proteins. 
 
Homology: Similarity in sequence, structure, or function between distinct proteins 
or DNA sequences. Sequence homology is used as a measure of relatedness, and 
sequences with high homology are said to be homologous. Homologous sequences 






HP1: Heterochromatin protein one, a scaffolding protein that binds H3K9me3 and 
recruits the DIM-2 DNA methyltransferase, the HCHC complex, the DMM complex, 
or mi-2. HP1 is required for DNA methylation and the establishment of 
heterochromatin. 
 
hpo: The gene for HP1 (heterochromatin protein one). 
 
Hygromycin: An antibiotic that is lethal to wild type Neurospora. The hph gene 
confers resistance to hygromycin. 
 
Knockout: An organism in which an existing gene was replaced (or disrupted) with 
an artificial sequence of DNA. 
 
Ligand: A small molecule that binds to a protein. Immobilized ligands can be used 
to bind and purify their interacting protein. 
 
Linearization: The use of a restriction enzyme to cut a plasmid, generating a linear 
segment of DNA. 
 
Linker: A flexible polypeptide sequence that connects two globular subunits of a 
protein. The use of a linker between affinity tags and recombinant proteins 
minimizes steric crowding (prevents the groups from bumping into each other) 
that could otherwise cause the protein to misfold. 
 
Locus: A specific site or region of the genome 
 
Methylation: The covalent addition of a methyl group to a target molecule. A 
methyl group is composed of a single carbon atom bonded to three hydrogen 
atoms. DNA and many proteins are often methylated. 
 
Nucleosome: The basic unit of chromatin. It consists of nuclear DNA coiled around 
an octamer protein complex containing two of each histone (H2A, H2B, H3, and 
H4). 
 
PCR: The polymerase chain reaction replicates DNA templates. The number of DNA 
copies doubles with every round of PCR replication. 
 
Pericentric: In close proximity to the centromere. Pericentric DNA is 
heterochromatic. 
 
Plasmid: A DNA ring. Plasmids are common in many species of bacteria. Plasmids 
are smaller than chromosomes, and more easily passed between cells. This makes 






Primer: A short nucleotide sequence (typically 20-30 bp) used to initiate DNA 
replication. The complementarity of the primer dictates where replication will be 
initiated.  
 
Probe:  A short DNA sequence that is complementary to a target sequence. Probes 
are often radiolabeled and applied to Southern blots, which allows the 
visualization of specific fragments. 
 
Promoter: A short DNA sequence that initiates transcription by recruiting 
transcription factors and RNA polymerase. Eukaryotes have a wide variety of 
diverse promoters. A gene's unique promoter is said to be its native promoter. 
 
PTM: A post-translational modification, most often of HP1 in the context of this 
paper. A post-translational modification is any chemical group that is covalently 
attached to a protein after it is translated from mRNA by the ribosome. 
Phosphorylation, methylation, acetylation, and formylation are all PTMs. 
 
Recombinant: A DNA segment containing genetic material from multiple sources. 
 
Recombination: The exchange of information between two DNA molecules. 
Recombination is primarily used to trade segments between chromosome copies 
prior to meiosis, increasing genetic diversity. Recombination most often occurs 
between highly similar (homologous) sequences. 
 
Restriction endonuclease: A group of enzymes that each cleave DNA at a specific 
sequence. Some restriction enzymes are methylation-sensitive, meaning they will 
only cut unmethylated targets. 
 
RIP: Repeat-induced point mutations, which Neurospora uses to silence 
transposons and duplicated sequences. RIP causes these repetitive sequence 
elements to become A:T-rich targets for DCDC. 
 
Scaffold protein: A protein that recruits other proteins and helps to facilitate their 
function, often by binding them in proximity to substrate with the proper 
orientation. 
 
Silencing: A partial or total decrease in gene expression caused by a regulatory 
process. In epigenetics, silencing is associated with DNA methylation, H3K9me3, 
and heterochromatin establishment. 
 
Site-directed mutagenesis: A variant of PCR that uses mismatched primers to 






Southern blotting: The transfer of DNA fragments from a gel onto a membrane. 
This allows the application of radiolabeled probes to visualize only the fragments 
of interest. 
 
Telomere: The heterochromatic ends of chromosomes. Replication causes 
degradation at the free ends of DNA, but the structure of telomeres helps to 
preserve genetic stability. 
 
Transcription: The process by which a DNA gene is used to make mRNA copies, 
which are later translated into a protein product. Transcription is the first step of 
gene expression. If a gene is expressed, it is also transcriptionally active. 
 
Transformation: The introduction of foreign DNA into a cell.  
 
Transposon: A DNA sequence that can change position within the genome. Many 
organisms, including Neurospora, silence transposons to prevent them from 
disrupting other genes. 
 
Western blotting: The transfer of proteins from a gel onto a membrane. Western 
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